Investors

Egetis is an innovative, unique, and integrated pharmaceutical drug development company, focusing on projects in late-stage development for treatment of serious rare/niche diseases with significant unmet medical needs in the orphan drug segment

Calendar


February 17, 2022 - Year-end-report
March 15-17 - Carnegie Healthcare Seminar
April 26, 2022 - Interim report January - March
May 10, 2022 - Annual General Meeting
August 19, 2022 - Half-year report January - June
November 8, 2022 - Interim report January - September

Share

Twitter
LinkedIn

Contact us

Address: Klara Norra Kyrkogata 26, SE 111 22 Stockholm, Sweden

Phone: +46 8 679 72 10

E-mail: info@egetis.com